ERBB2 and breast carcinoma: Only case reports of successful cases have been reported regarding the effects of endocrine therapy (tamoxifen, megesterol acetate, letrozole, fulvestrant) on BM for ER-positive and HER2-negative breast cancer, and efficacy has not been confirmed in clinical trials [110].